Description: Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It develops, promotes, and sells a portfolio of single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prevention, as well as respiratory diseases and diabetes. The company is headquartered in Monheim am Rhein, Germany.
Home Page: apontis-pharma.de
Alfred-Nobel-Str. 10
Monheim am Rhein,
40789
Germany
Phone:
49 2173 8955 4949
Officers
| Name | Title |
|---|---|
| Mr. Karlheinz Gast | Chairman of the Management Board & CEO |
| Mr. Thomas Milz | Chief Product Officer & Deputy Chairman of Management Board |
| Mr. Thomas Zimmermann | Chief Financial Officer |
| Mr. Harald Weyand | Head of Marketing |
| Dr. Matthias Wendl | Head of Sales |
| Ms. Susanne Böhm | Head of HR |
| Dr. Olaf Randerath | Head of Medicine |
| Dr. Susanne Endreß | Head of QA, Drug Safety & Regulatory Affairs |
Exchange: XETRA
Country: DE
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 20.4444 |
| Price-to-Book MRQ: | 1.7527 |
| Price-to-Sales TTM: | 1.3063 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 127 |